Complement Factor H Inhibits CD47-Mediated Resolution of Inflammation

Area of Science:

• Ophthalmology
• Immunology
• Genetics

Background:

• Age-related macular degeneration (AMD) is a leading cause of blindness.
• Complement factor H (CFH) gene variants are strongly associated with AMD.
• The precise role of CFH in AMD pathogenesis remains to be fully elucidated.

Purpose of the Study:

• To investigate the contribution of CFH to the etiology of age-related macular degeneration (AMD) using murine models.
• To elucidate the molecular mechanisms by which CFH influences immune cell dynamics in the context of AMD.
• To explore potential therapeutic strategies targeting CFH-mediated pathways.

Main Methods:

• Utilized murine models to study AMD pathogenesis.
• Examined the role of CFH in the accumulation and clearance of mononuclear phagocytes (MP) in the subretinal space.
• Investigated the interaction between CFH, CD11b, thrombospondin-1 (TSP-1), and CD47.
• Assessed the impact of the AMD-associated CFH(H402) variant.
• Evaluated a model of acute sterile peritonitis to assess broader applicability.

Main Results:

• Cfh deletion protected mice from pathogenic MP accumulation and accelerated inflammation resolution in an AMD model.
• CFH binding to CD11b obstructed MP clearance from the subretinal space by inhibiting TSP-1-mediated CD47 activation.
• The AMD-associated CFH(H402) variant significantly enhanced this inhibitory effect on microglial cells.
• Similar mechanisms were observed in a sterile peritonitis model, indicating broader relevance.
• Pharmacological CD47 activation accelerated the resolution of both ocular and peritoneal inflammation.

Conclusions:

• CFH plays a critical role in AMD pathogenesis by impeding the homeostatic clearance of mononuclear phagocytes.
• The interaction between CFH, CD11b, and CD47 represents a key mechanism in regulating inflammatory resolution.
• Targeting CD47 activation offers a promising therapeutic strategy for chronic inflammatory diseases, including AMD.